Efficacy of Indonesian Asthmatic Gymnastic as Combine Pulmonary Rehabilitation Based on Asthma Classification

March 13, 2026 updated by: RSUP Persahabatan

EFFICACY OF INDONESIAN ASTHMATIC GYMNASTIC AS COMBINE PULMONARY REHABILITATION IN ASTHMATIC PATIENT BASED ON ASTHMA CLASSIFICATION

This study aims to evaluate the efficacy of Indonesian Asthma Gymnastic for stable asthmatic patients in all asthma classification. The outcome measurements includes 6 minutes walk test, Asthma Control Test, peak flow rate value, and lung function. All participants have been in routine standard treatment of asthma (medication, education of healthy life style and smoking cessation).

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

35

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Indonesia
      • Jakarta, Indonesia
        • Recruiting
        • RSUP Persahabatan
        • Contact:
        • Contact:
          • Siti C Widjanantie
          • Phone Number: +62 81348639827
        • Sub-Investigator:
          • Veronika R Kurniawati

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Diagnosed with stable asthma
  • Age 18-65 years old
  • Competent and willing to be included in the trial

Exclusion Criteria:

  • Asthma exacerbation
  • Had other lung disease
  • Had neuromuscular disease affecting respiratory system

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental: IAG group
Other: Indonesian Asthma Gymnastic exercise
Aerobic structured exercise designed for asthmatic patient consists of 8 phase: warming up, stretching, core movement I, core movement II, aerobics I-III, and cooling down

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change in 6 minutes walk distance
Time Frame: Baseline, 4 weeks
Baseline, 4 weeks
Asthma Control Test score
Time Frame: Baseline, 4 weeks
Baseline, 4 weeks
Change in Forced Expiratory Volume in 1 second, Forced Vital Capacity, and FEV1/FVC ratio
Time Frame: Baseline, 4 weeks
Baseline, 4 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
Change of peak flow rate
Time Frame: Baseline, 1 week, 2 weeks, 3 weeks, 4 weeks
Baseline, 1 week, 2 weeks, 3 weeks, 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

RSUP Persahabatan

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 6, 2025

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

September 1, 2026

Study Registration Dates

First Submitted

March 13, 2026

First Submitted That Met QC Criteria

March 13, 2026

First Posted (Actual)

March 18, 2026

Study Record Updates

Last Update Posted (Actual)

March 18, 2026

Last Update Submitted That Met QC Criteria

March 13, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 0135/KEPK-RSUPP/07/2025

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe